Market Tracker

11/22 9:46am ET

Haemonetics Corp (NYSE:HAE)

58.54
Delayed Data
As of 9:30am ET
 -0.45 / -0.76%
Today’s Change
36.44
Today|||52-Week Range
58.99
+45.62%
Year-to-Date
Haemonetics (HAE) at 52-Week High: What's Driving the Stock?
Nov 20 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Q2 Earnings Beat Estimates, EPS View Up
Nov 08 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Grows on Strong Plasma, Competition Rife
Nov 15 / Zacks.com - Paid Partner Content
Haemonetics (HAE) in Focus: Stock Moves 10% Higher
Nov 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close58.99
Today’s open58.61
Day’s range58.54 - 58.66
Volume11,613
Average volume (3 months)367,206
Market cap$3.1B
Dividend yield--
Data as of 9:30am ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+53.21%
Earnings growth (this year)+11.19%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)-2.68%
P/E ratio836.3
Price/Sales2.36
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc-0.05-0.11%
MMSIMerit Medical System...+0.35+0.80%
INGNInogen Inc-0.17-0.14%
NXTMNxStage Medical Inc-0.09-0.34%
Data as of 9:31am ET, 11/22/2017

Financials

Next reporting dateJanuary 29, 2018
EPS forecast (this quarter)$0.44
Annual revenue (last year)$886.1M
Annual profit (last year)-$26.3M
Net profit margin-2.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts